Journal of Eye Diseases and Disorders

Emerging Trends in Ocular Drug Delivery: A Review on Recent Updates

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities

Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery

Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions

Genome-wide CNV investigation suggests a role for cadherin, Wnt, and p53 pathways in primary open-angle glaucoma

Reconstruction of delayed scleral flap melting with bovine pericardium after trabeculectomy with mitomycin C

Surgery for glaucoma in patients with facial port wine mark

Pathophysiology, diagnosis, and management of glaucoma associated with Sturge-Weber syndrome

McElnea E, Naughton A, O’Brien C, Keegan D. Un-doing All that Good Work. Glaucoma After Vitrectomy and Silicone Oil. 2016:2.

McElnea E, Naughton A, O’Brien C, Keegan D. Un-doing All that Good Work. Glaucoma After Vitrectomy and Silicone Oil. 2016:2.

McElnea E, Naughton A, O’Brien C, Keegan D. Un-doing All that Good Work. Glaucoma After Vitrectomy and Silicone Oil. 2016:2.

Exfoliation syndrome: A disease of autophagy and LOXL1 proteopathy

The History of Exfoliation Syndrome

Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates

The History of Exfoliation Syndrome

Recent advances in risk factors associated with ocular exfoliation syndrome

Exfoliation syndrome: A disease of autophagy and LOXL1 proteopathy

The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma

Molecular Biology of Exfoliation Syndrome